AIMC Topic: Glioblastoma

Clear Filters Showing 21 to 30 of 213 articles

Radiogenomics and machine learning predict oncogenic signaling pathways in glioblastoma.

Journal of translational medicine
BACKGROUND: Glioblastoma (GBM) is a highly aggressive brain tumor associated with a poor patient prognosis. The survival rate remains low despite standard therapies, highlighting the urgent need for novel treatment strategies. Advanced imaging techni...

Deep learning classification of MGMT status of glioblastomas using multiparametric MRI with a novel domain knowledge augmented mask fusion approach.

Scientific reports
We aimed to build a robust classifier for the MGMT methylation status of glioblastoma in multiparametric MRI. We focused on multi-habitat deep image descriptors as our basic focus. A subset of the BRATS 2021 MGMT methylation dataset containing both M...

Brain tumour histopathology through the lens of deep learning: A systematic review.

Computers in biology and medicine
PROBLEM: Machine learning (ML)/Deep learning (DL) techniques have been evolving to solve more complex diseases, but it has been used relatively little in Glioblastoma (GBM) histopathological studies, which could benefit greatly due to the disease's c...

Differentiation of glioblastoma G4 and two types of meningiomas using FTIR spectra and machine learning.

Analytical biochemistry
Brain tumors are among the most dangerous, due to their location in the organ that governs all life processes. Moreover, the high differentiation of these poses a challenge in diagnostics. Therefore, this study focused on the chemical differentiation...

Survival prediction of glioblastoma patients using machine learning and deep learning: a systematic review.

BMC cancer
Glioblastoma Multiforme (GBM), classified as a grade IV glioma by the World Health Organization (WHO), is a prevalent and notably aggressive form of brain tumor derived from glial cells. It stands as one of the most severe forms of primary brain canc...

Radiomics and deep learning models for glioblastoma treatment outcome prediction based on tumor invasion modeling.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
PURPOSE: We investigate the feasibility of using a biophysically guided approach for delineating the Clinical Target Volume (CTV) in Glioblastoma Multiforme (GBM) by evaluating its impact on the treatment outcomes, specifically Overall Survival (OS) ...

Ensemble learning-based radiomics model for discriminating brain metastasis from glioblastoma.

European journal of radiology
OBJECTIVE: Differentiating between brain metastasis (BM) and glioblastoma (GBM) preoperatively is challenging due to their similar imaging features on conventional brain MRI. This study aimed to enhance diagnostic accuracy through a machine learning ...

Assessment of MGMT promoter methylation status in glioblastoma using deep learning features from multi-sequence MRI of intratumoral and peritumoral regions.

Cancer imaging : the official publication of the International Cancer Imaging Society
OBJECTIVE: This study aims to evaluate the effectiveness of deep learning features derived from multi-sequence magnetic resonance imaging (MRI) in determining the O-methylguanine-DNA methyltransferase (MGMT) promoter methylation status among glioblas...

CXCL12 impact on glioblastoma cells behaviors under dynamic culture conditions: Insights for developing new therapeutic approaches.

PloS one
Glioblastoma multiforme (GBM) is the most prevalent malignant brain tumor, with an average survival time of 14 to 20 months. Its capacity to invade brain parenchyma leads to the failure of conventional treatments and subsequent tumor recurrence. Rece...

Convolutional neural network-assisted Raman spectroscopy for high-precision diagnosis of glioblastoma.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Glioblastoma multiforme (GBM) is the most lethal intracranial tumor with a median survival of approximately 15 months. Due to its highly invasive properties, it is particularly difficult to accurately identify the tumor margins intraoperatively. The ...